Lecanemab is the first medication approved in Canada that targets the buildup of amyloid plaque in the brain, which is ...
Ottawa Citizen on MSN
Approval of new Alzheimer's drug in Canada called historic
The approval of a new drug that can slow the progress of Alzheimer’s disease is being hailed as a historic moment in the ...
Phase 3 clinical trial results of an investigational drug has shown benefits in treating people with APOE4/4 with early ...
Two widely available medicines can safely improve brain health in those with early Alzheimer’s disease, a new study has found ...
A new vitamin K-based treatment could help replenish lost neurons in Alzheimer's patients, offering hope for slowing ...
After decades of unsuccessful research, two new drugs and a pioneering blood test have recently given Alzheimer's patients hope of fighting back against the debilitating disease - but questions remain ...
The NDA submission is supported by data from two pivotal Phase 3 clinical trials, which evaluated MK-6240’s performance in detecting tau pathology in early Alzheimer’s disease. These studies met their ...
Farmington Hills, Michigan, Oct. 23, 2025 (GLOBE NEWSWIRE) -- “We made every effort to bring this treatment to U.S. patients first,” said Cerezen Founder and CEO Manoj Bhargava. “However, it seems ...
The diabetes drug empagliflozin (Jardiance) and an insulin nasal spray both showed promising effects on memory, brain health ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback